Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Chief Counsel Stacy Cline Amin Guided Agency Through COVID-19 EUAs And Guidances

Jan 12 2021

• By Brenda Sandburg

Departure — FDA Chief Counsel Stacy Cline Amin leaves agency • Source: Shutterstock

Related Content

Transition Day In The US: 96 Drugs Make The Move To Biologics Regulation

Mar 23 2020

Some Long-Standing FDA Regs Face Mandatory Review Or Rescission Under New HHS Rule

Jan 09 2021

US FDA Faces Succession Questions As Hahn’s Departure Nears

Jan 06 2021

From White House To White Oak: US FDA Taps Stacy Cline Amin For Chief Counsel Post

Sep 07 2018

FDA Chief Counsel Defends COVID-19 EUAs, Praises ‘Moral Strength’ Of Commissioner Hahn

Oct 09 2020

FDA Looks Inside For Chief Counsel, Taps Elizabeth Dickinson

Mar 05 2012

Plasma Authorization Raises Fears Of Politically-Influenced COVID-19 Vaccine Decisions, Compromised FDA

Aug 25 2020

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Additional Topics

United States FDA Leadership Legal Issues Coronavirus COVID-19 Policy Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window